Top Tweets for #Catalym
#CatalYm Announces First Patient Dosed in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Metastatic Non-squamous NSCLC. $PFE https://t.co/oDm6Qe2Uzy
#CatalYm Announces First Patient Dosed in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as First-Line Treatment in Metastatic Non-squamous NSCLC. $PFE $LPTX https://t.co/DnjUT16kDV
#CatalYm Announces Leadership Changes to Accelerate Visugromab Late-stage Clinical Development. $LPTX $PFE https://t.co/hSKGApkU1f
Attending today’s #AACR25 Major Symposium on cancer cachexia to hear talks by @JanowitzTobias and others? You’ll be interested in the recently published Cancer Discovery News story titled “Ponsegromab Promotes Weight Gain for Cancer Cachexia.” https://t.co/KlDQl7udjI
$pfe $lptx #catalym GDF-15 blockade: A multi-directional approach to potentiate cancer immunotherapy and alleviate cancer cachexia
https://t.co/fdRTN4o4Gy
$lptx $pfe #catalym <gdf-15 drives adc resistance?> New data: Visugromab targets ADC resistance mechanism
$lptx #catalym (gdf-15)Scrip Asks... What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances
https://t.co/9U6TERWQqu
GDF-15 as a Biomarker for Diagnosis and Prognosis of Lung Cancer: A Meta-Analysis
https://t.co/99S4nXCGPC
#catalym <gdf-15> Reversing cancer mechanisms to fight back against solid tumors
https://t.co/Rdkaf2tNHh
$lptx $pfe #catalym: Growth Differentiation Factor 15 in Heart Failure and Cancer
https://t.co/s44tvS7052
ICYMI: "GDF-15 Blockade Overcomes Resistance to Immune Checkpoint Inhibition" https://t.co/3qi4irOY1W
A #ResearchWatch summary of a study by @DrIgMelero, Eugen Leo, and colleagues @ClinicaNavarra @CIMA_unav #visugromab #CatalYm
$lptx $pfe #catalym nice video summary on cachexia and ponsegromab results. Dr. also mentions hf a d HIV/aids cachexia
https://t.co/CIT7sKKCwA
Ph I/II GDFATHER trial anti-GDF-15 visugromab+/-Nivo @Nature
- 27pts w NSCLC
- ORR 19.5% nonsq
- 4CRs in NSCLC, UC, HCC
With activity in IO resistance & cancer cachexia, is anti-GDF-15 the godfather of agents?
@OncoAlert #LCSM https://t.co/fXad27YrBU
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.3M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers